Introduction
The production of cDNA clones from which infectious RNA can be transcribed in vitro has become an essential tool for molecular genetic studies of positive-strand RNA viruses. This was first achieved for brome mosaic virus, for which full-length cDNA copies of each of the three genomic RNAs were linked to a modified phage lambda PR promoter (PM) in the vector pPM1 and transcribed in vitro using Escherichia coli RNA polymerase . A similar approach was used to obtain infectious in vitro transcripts from cDNA clones of tobacco mosaic virus (Dawson et al., 1986; Meshi et al., 1986) , black beetle virus (Dasmahapatra et al., 1986) and poliovirus (Kaplan et al., 1985) . A limitation on the production of infectious transcripts using E. coli RNA polymerase has been the variable efficiency of different commercial batches of the enzyme Janda et al., 1987) . This has led to the use of more efficient and reliable RNA polymerases from bacteriophages T3, T7 and SP6 for the synthesis of infectious transcripts from cDNA clones of a range of plant viruses (Janda et al., 1987; Vos et al., 1988; Domier et al., 1989; Eggen et al., 1989a, b; Heaton et al., 1989; Petty et al., 1989; Quillet et al., 1989; Weiland & Dreher, 1989) , animal viruses (van der Werf et al., 1986; Rice et al., 1987) and bacteriophage Qfl (Shaklee et al., 1988) .
The most common procedure to produce eDNA clones from which infectious transcripts can be obtained has involved cloning full-length double-stranded eDNA into a vector containing the appropriate bacteriophage promoter. In vitro mutagenesis has been used to eliminate, or reduce the number of, nucleotides between the transcription initiation site and the 5' end of the viral RNA because the presence of more than one additional 5' nucleotide can greatly reduce or abolish the infectivity of the transcripts (Janda et al., 1987; Eggen et al., 1989a) . However, Weiland & Dreher (1989) have recently described a procedure in which an oligonucleotide containing a T7 promoter linked directly to the 5' viral sequence is used to prime second-strand eDNA synthesis, allowing the eDNA to be cloned into standard vectors and eliminating the need for in vitro mutagenesis. We now describe an adaptation of this procedure in which the production and cloning of fulllength cDNAs are considerably facilitated by amplification using the polymerase chain reaction (PCR) (Saiki et al., 1988) . The procedure has been used to obtain eDNA clones of cucumber mosaic virus (CMV), from which infectious transcripts have been synthesized in vitro.
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Methods
Virus and viral RNA. Nicotiana tabacum cv. Samsun plants were grown at 20 °C under a mixture of fluorescent and tungsten lighting for 15 h per day. Seedlings with four to six leaves were inoculated with CMV Q-strain (CMV-Q) (Habili & Francki, 1974) obtained from the American Type Culture Collection. Plants were harvested 10 days after inoculation and virus was isolated and purified as described by Lot et al. (1974) . Viral RNA was extracted from purified virus particles as in Peden & Symons (1973) .
Oligonucleotides. These were synthesized using an Applied Biosystems Model 381A DNA synthesizer.
Cloning. General procedures were as in Sambrook et al. (1989) , unless otherwise stated.
Construction of pCMVI-(A to E), pCMV2-(A to E) and pCMV3-(A to E)
. First-strand cDNA was synthesized using RNA isolated from purified CMV particles as a template, an oligonucleotide primer ( Fig.  1 ) and reverse transcriptase and other reagents from an Amersham cDNA Synthesis System Kit with conditions as described by the manufacturer. The product was electrophoresed through an alkaline l-2% low melting temperature agarose gel. After neutralization of the gel and staining with ethidium bromide, distinct bands corresponding to full-length cDNA couid be detected. These cDNAs were purified from the gel by melting the agarose at 65 °C, two rounds of phenol :chloroform extraction and precipitation with ethanol. Each cDNA product was then used as a template for a PCR. Reaction mixtures (100 gl) contained 67 mM-Tris-HC1 pH 8.8 at 25 °C, 17 raMammonium sulphate, 2'mM-magnesium chloride, 10 mM-2-mercaptoethanol, 0-2 gg/ml bovine serum albumin, 6.5 gM-EDTA, 0.2 mMdNTPs (dATP, dCTP, dGTP, dTTP), 1 gg of each primer and 2 units AmpliTaq (Cetus), and were subject to a 30 cycle programme of 92 °C for 1 min, 40 °C for 1 min and 72 °C for 3 rain. The oligonucleotide described above was used as the first-strand primer and three separate oligonucleotides were used for second-strand priming of RNA 1, RNA 2 and RNA 3 respectively (Fig. 1) . The PCR products were extracted with phenol, precipitated with ethanol, resuspended and digested with BamHl overnight. The products were then electrophoresed through a 1% low melting temperature agarose gel and the full-length doublestranded cDNA products were purified, ligated into BamHI-cleaved pEMBL9(+) (Dente et al., 1985) and transformed into E. coli DH5-alpha F' cells (Gibco-BRL) using a Bio-Rad Gene Pulser according to the manufacturer's instructions. Recombinant plasmids were purified by the method of Birnboim & Doly (1979) and those containing fulllength cDNA corresponding to RNA 1, RNA 2 and RNA 3 were identified by restriction mapping and plasmid sequencing (Chen & Seeberg, 1985) . , pCMV1G, pCMV2GG, pCMV2G, pCMV3GG and pCMV3G . Plasmid pTZ18U (Mead et al., 1986) contains a T7 promoter adjacent to a polylinker sequence from pUCIS. The sequence AGGGAA which contains the T7 transcriptional start site at its first G was converted by in vitro mutagenesis (Kunkel et al., 1987) to the sequence AGGCCT which is a StuI site. The resultant plasmid was designated pTZ18S. Double-stranded cDNA to CMV RNA l, RNA 2 and RNA 3 was produced by the PCR as described above using the same first-strand primer (Fig. 1) . The second-strand primers were: RNA 1, GTTTTATTTACAAGA (pCMV1GG) or TTTTATTTACAAGA (pCMV1G); RNA 2, GTTTATTCUCAA-GAG (pCMV2GG)or TTTATTCUCAAGAG (pCMV2G); RNA 3, GTAATCTTACCACTT (pCMV3GG) or TAATCTTACCACTT (pCMV3G). The PCR products were cleaved with BamHI and cloned into StuI/BamHI-cleaved pTZ18S. Clones containing full-length cDNAs of RNA 1, RNA 2 and RNA 3 were identified by restriction mapping and sequences adjacent to the T7 transcriptional start site were confirmed by plasmid sequencing (Chen & Seeberg, 1985) .
Construction of pCMVIGG
In vitro transcription. Reaction mixtures (100 pl) contained 40 mMTris-HCl pH 8.0, 15 mM-magnesium chloride, 5 mM-dithiothreitol, 0.5 mg/ml bovine serum albumin, 1 mM-ATP, 1 mM-UTP, 1 mM-CTP, 0.5 mM-GTP, 2 mM-mTGpppG (Pharmacia), 100 units Inhibit-Ace (Northumbria Biologicals), 150 units T7 RNA polymerase (Gibco-BRL) and 10 gg each of BamHI-linearized cDNA clones of RNAs 1, 2 and 3. The transcribed RNA was purified by treatment with DNase I to remove the template, followed by phenol extraction and ethanol precipitation.
Inoculation of plants with in vitro synthesized transcripts. N. tabacum cv. Samsun seedlings with four to six leaves were inoculated with in vitro transcripts (50 gg/ml of each transcript) as described by Osman & Buck (1989) and cultivated as described above. Plants were harvested 10 days after inoculation. Do,blot hybridization. RNA was extracted from leaf tissue, spotted onto Hybond-N membranes (Amersham) and hybridized with 32p. labelled probes as described by Osman & Buck (1989) .
Gel electrophoresis of proteins. Samples of purified virus were adjusted to 1% SDS and 2% 2-mercaptoethanol and heated at 100 °C for 3 rain. Aliquots were fractionated by electrophoresis in 15% polyacrylamide gels using the discontinuous buffer system described by Laemmli (1970) .
Immunodiffusion. Gel immunodiffusion analysis was as described by Osman et al. (1986) .
Electron microscopy. Samples were stained in 1% phosphotungstic acid and examined in an electron microscope.
Results
Use of PCR for production of cDNA clones
CMV has a genome of three positive-strand RNA components, RNA 1 (3.4 kb), RNA 2 (3.0 kb) and RNA 3 (2.1 kb), which encode non-structural proteins la, 2a and 3a, respectively (Gould & Symons, 1982; Rezaian et al., 1984 Rezaian et al., , 1985 . RNA 3 also encodes the coat protein which is expressed from R N A 4 (1-0 kb), a subgenomic R N A which is 3'-coterminal with RNA 3. All four RNAs are encapsidated.
The PCR (Saiki et al., 1988) was used to obtain fulllength clones of the three genomic RNAs of CMV. The 3'-terminal sequences of RNA 1, R N A 2 and R N A 3 are identical. Hence, a single oligonucleotide containing a sequence complementary to the 3'-terminal 16 nucleotides ( Fig. 1 ) was used to prime c D N A synthesis on all the viral RNAs. After electrophoresis of the products of first-strand cDNA synthesis in an alkaline denaturing gel, distinct bands corresponding to full-length cDNA of each RNA were detected. Bands corresponding in size to RNA 1, RNA 2 and RNA 3 were extracted from the gel and each was amplified separately in a PCR. Gel electrophoresis of the PCR products of each RNA is shown in Fig. 2 . Single bands of 3.4 kb, 3.0 kb and 2.1 kb were detected for the PCR products of RNA 1, RNA 2 and RNA 3 respectively. Attempts to use PCR on the unpurified first-strand c D N A reaction products were not successful, yielding products of less than 1.5 kb. Both the first-strand and second-strand primers ( Fig.  1) were designed to contain a BamHI site at their extremities to facilitate cloning of the full-length doublestranded cDNA into the BamHI site of pEMBL9(+).
The second-strand primers also contained the T7 ~bl0 promoter (Dunn & Studier, 1983) linked to 15 nucleotides corresponding to the 5' sequence of each RNA. Since the 5' sequences of RNA 1, R N A 2 and RNA 3 differ slightly, a separate second-strand primer was needed for each RNA (Fig. 1) . Sequence analysis of fulllength clones of RNA 1, R N A 2 and R N A 3 in p E M B L 9 ( + ) showed that the sequences of the primers were present in all the clones. Five independent clones of each RNA were obtained and are designated as follows: R N A 1 clones, pCMV1-A, pCMV1-B, pCMV1-C, pCMV1-D, pCMV1-E; RNA 2 clones, pCMV2-A, pCMV2-B, pCMV2-C, pCMV2-D, pCMV2-E; RNA 3 clones, pCMV3-A, pCMV3-B, pCMV3-C, pCMV3-D, pCMV3-E.
The T7 class III promoters, which include q~10 (Dunn & Studier, 1983) , have exactly the same sequence of 23 base pairs located at positions -17 to + 6 relative to the start site for the RNA (designated + 1). This implies that the transcriptional efficiency may depend on sequences downstream as well as upstream of the start site. The design of the pCMV1, pCMV2 and pCMV3 clones to allow transcription to start precisely at the 5' end of each R N A required a change to the sequence downstream of the transcriptional initiation site of the T7 ~b 10 promoter. For comparison, two further sets of plasmids were constructed, as described in the Methods section, with one or two additional G residues upstream of the 5' end of each RNA, so as to more closely resemble the T7 initiation sequence. These are designated pCMV1G, pCMV2G, pCMV3G and pCMV 1GG, p C M V 2 G G and pCMV3GG, respectively. The sequences around the transcriptional initiation sites of the three plasmids are compared with that of the T7 ~bl0 promoter in Fig. 3 .
In vitro transcription
Transcription of BamHI-linearized pCMVI-(A to E), pCMV2-(A to E) and pCMV3-(A to E) by T7 RNA polymerase generated RNAs that comigrated with the CMV virion RNAs 1, 2 and 3, respectively, in denaturing gels (shown for pCMV1-A, pCMV2-A and pCMV3-A in Fig. 4 ). The amount of transcript obtained corresponded to about five transcripts per plasmid. Similar results were obtained whether or not the cap analogue mTGpppG was present in the reaction mixture. Transcription of linearized pCMV1G, pCMV2G, pCMV3G, pCMV1GG, p C M V 2 G G and p C M V 3 G G with T7 R N A polymerase gave similar results (not shown), except that the yields of transcripts were higher. In the case of the latter three plasmids, yields of up to 20 transcripts per plasmid were obtained.
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Infectivity and symptom induction
The results of inoculation of N. tabacum cv. Samsun, a systemic host for CMV, with transcripts produced from different plasmids are shown in Table 1 . Infectivity was demonstrated for capped transcripts of the combinations: pCMV1-A, pCMV2-A, pCMV3-A; pCMV1-B, pCMV2-B, pCMV3-B; pCMV1-C, pCMV2-C, pCMV3-C; pCMV1-D, pCMV2-D, pCMV3-D; pCMV1-E, pCMV2-E, pCMV3-E. Infectivity was reduced either by the absence of a cap structure or by the addition of one or two G residues to the 5' end of the transcripts. With one exception the symptoms induced in the N. tabacum plants by the transcripts were similar to those induced by virions or RNA of CMV-Q and consisted of a mild mosaic on the systemically infected leaves. However, the symptoms induced by transcripts of pCMV1-E, pCMV2-E and pCMV3-E were much more severe. A bright yellow mosaic appeared on the systemic leaves which eventually became completely chlorotic (Fig. 5) .
Virus preparations were made from plants infected by transcripts from pCMV1-A, pCMV2-A and pCMV3-A (A transcripts) and from pCMV1-E, pCMV2-E and pCMV3-E (E transcripts) and were designated CMV-TA and CMV-TE respectively. Particles of CMV-TA and CMV-TE were indistinguishable from each other and from CMV-Q by electron microscopy and by gel diffusion serology. Plants inoculated with CMV-TA or CMV-TE became infected and the symptoms induced were the same as those induced by A transcripts or E transcripts respectively. RNA was extracted from preparations of CMV-TA or CMV-TE and examined by electrophoresis in a denaturing agarose gel. Bands with mobilities identical to RNAs 1, 2, 3 and 4 of CMV-Q were detected in each case (not shown). Analysis of protein from virus preparations of CMV-TA or CMV-TE by SDS-PAGE in each case gave a major band with the same mobility as that of protein from preparations of CMV-Q. 
Discussion
We have found that cloning of full-length cDNAs of CMV RNAs is facilitated by amplification of cDNAs using the PCR and that infectious transcripts can be synthesized in vitro from such clones. The error rate (mutations per base duplication) of Taq polymerase used in the PCR reactions has been estimated to be 2 × 10 -4 (Keohavong & Thilly, 1989) . Mutations may therefore be expected to accumulate in a population of DNA molecules as a function of the number of cycles of amplification. It is clear that any mutations introduced during the PCR in the present study were not lethal to the virus because all the clones tested gave rise to infectious
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RNA transcripts. Furthermore, most of the clones gave symptoms indistinguishable from CMV-Q, which was used as the source of RNA for eDNA synthesis. However, it is noteworthy that transcripts from clones pCMV1-E, pCMV2-E and pCMV3-E induced more severe symptoms than CMV-Q and a mutation must therefore be present in at least one of these clones. We cannot be certain whether this mutation arose during the PCR, during reverse transcription or as a spontaneous mutation in the population of CMV-Q RNA molecules during propagation of the virus. Reverse transcriptases and RNA-dependent RNA polymerases are also known to have relatively high error rates (Gopinathan et al., 1979; Steinhauer & Holland, 1987) . Nevertheless amplification of eDNA by the PCR may be worthy of investigation as a method of generating virus mutants. The finding that infectivity was reduced by addition of one G residue, and to a greater extent by two G residues, to the 5' end of the transcripts (Table 1) confirms the importance of the Y-terminal structure of transcripts for infectivity (Dawson et al., 1986; Van der Werf et al., 1987; Janda et al., 1987; Rice et al., 1987; Shaklee et al., 1988; Eggen et al., 1989a; Heaton et al., 1989) but, in contrast, infectivity appears to be relatively insensitive to T-terminal extensions (Janda et al., 1987; Eggen et al., 1989b) . BamHI-cleaved pCMVI-(A to E), pCMV2-(A to E) and pCMV3-(A to E) contained four additional nucleotides beyond the 3' terminus of the RNAs; however, there was little difference between the infectivity of the transcripts and that of CMV-Q RNA. As with in vitro transcripts of other viruses, the presence of a 5'-terminal cap structure was necessary for maximum infectivity.
The availability of eDNA clones from which infectious RNA can be transcribed will greatly facilitate molecular genetic studies with CMV. Furthermore, analysis of the mutant clones which give more severe symptoms on N. tabacum should be informative with regard to the molecular basis of the pathogenicity of this virus.
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